Operating Expenses Summary of RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ)'s latest annual operating expenses in 2023 was 800.7 Million SEK , down -28.98% from previous year.
RaySearch Laboratories AB (publ)'s latest quarterly operating expenses in 2024 Q1 was 119.57 Million SEK , down -18.9% from previous quarter.
RaySearch Laboratories AB (publ) reported a annual operating expenses of 718.35 Million SEK in annual operating expenses 2022, up 9.62% from previous year.
RaySearch Laboratories AB (publ) reported a annual operating expenses of 655.31 Million SEK in annual operating expenses 2021, up 12.49% from previous year.
RaySearch Laboratories AB (publ) reported a quarterly operating expenses of 119.57 Million SEK for 2024 Q1, down -18.9% from previous quarter.
RaySearch Laboratories AB (publ) reported a quarterly operating expenses of 510.13 Million SEK for 2023 FY, down -28.98% from previous quarter.

Annual Operating Expenses Chart of RaySearch Laboratories AB (publ) (2023 - 2003)

Historical Annual Operating Expenses of RaySearch Laboratories AB (publ) (2023 - 2003)

Year	Operating Expenses	Operating Expenses Growth
2023	800.7 Million SEK	-28.98%
2022	718.35 Million SEK	9.62%
2021	655.31 Million SEK	12.49%
2020	582.56 Million SEK	-6.07%
2019	620.23 Million SEK	23.65%
2018	501.58 Million SEK	34.69%
2017	372.4 Million SEK	17.72%
2016	316.33 Million SEK	11.74%
2015	283.11 Million SEK	38.62%
2014	204.23 Million SEK	-8.76%
2013	223.85 Million SEK	45.17%
2012	154.2 Million SEK	57.29%
2011	98.03 Million SEK	26.07%
2010	77.76 Million SEK	85.98%
2009	41.81 Million SEK	2.05%
2008	40.97 Million SEK	7.65%
2007	38.06 Million SEK	22.11%
2006	31.17 Million SEK	-4.16%
2005	32.52 Million SEK	38.77%
2004	23.43 Million SEK	92.31%
2003	12.18 Million SEK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	215.12 Million SEK	80.48%
2024 Q1	119.57 Million SEK	-18.9%
2023 FY	510.13 Million SEK	-28.98%
2023 Q3	193.43 Million SEK	-2.9%
2023 Q2	199.21 Million SEK	9.11%
2023 Q1	182.57 Million SEK	-16.23%
2023 Q4	147.43 Million SEK	-23.78%
2022 Q4	217.94 Million SEK	28.12%
2022 Q2	166.36 Million SEK	1.49%
2022 Q1	163.93 Million SEK	-20.0%
2022 FY	718.35 Million SEK	9.62%
2022 Q3	170.1 Million SEK	2.25%
2021 Q3	156.53 Million SEK	-1.7%
2021 FY	655.31 Million SEK	12.49%
2021 Q1	134.62 Million SEK	-0.82%
2021 Q4	204.91 Million SEK	30.91%
2021 Q2	159.24 Million SEK	18.29%
2020 Q2	163.24 Million SEK	14.1%
2020 Q1	143.06 Million SEK	-30.33%
2020 Q4	135.72 Million SEK	-3.41%
2020 FY	582.56 Million SEK	-6.07%
2020 Q3	140.51 Million SEK	-13.92%
2019 Q3	143.18 Million SEK	-3.53%
2019 Q2	148.42 Million SEK	20.4%
2019 Q4	205.34 Million SEK	43.42%
2019 FY	620.23 Million SEK	23.65%
2019 Q1	123.27 Million SEK	-30.86%
2018 FY	501.58 Million SEK	34.69%
2018 Q4	178.29 Million SEK	39.97%
2018 Q3	127.38 Million SEK	23.41%
2018 Q2	103.21 Million SEK	11.36%
2018 Q1	92.68 Million SEK	15.67%
2017 FY	372.4 Million SEK	17.72%
2017 Q1	83.34 Million SEK	-6.02%
2017 Q3	105.06 Million SEK	1.15%
2017 Q2	103.86 Million SEK	24.63%
2017 Q4	80.12 Million SEK	-23.74%
2016 Q1	66.79 Million SEK	-17.49%
2016 FY	316.33 Million SEK	11.74%
2016 Q2	75.83 Million SEK	13.53%
2016 Q3	85.02 Million SEK	12.12%
2016 Q4	88.68 Million SEK	4.3%
2015 FY	283.11 Million SEK	38.62%
2015 Q3	74.74 Million SEK	-3.28%
2015 Q4	80.95 Million SEK	8.31%
2015 Q2	77.28 Million SEK	54.17%
2015 Q1	50.12 Million SEK	-16.08%
2014 Q2	48.26 Million SEK	6.39%
2014 FY	204.23 Million SEK	-8.76%
2014 Q4	59.73 Million SEK	17.41%
2014 Q3	50.87 Million SEK	5.4%
2014 Q1	45.36 Million SEK	-47.41%
2013 Q4	86.26 Million SEK	62.41%
2013 FY	223.85 Million SEK	45.17%
2013 Q3	53.11 Million SEK	18.07%
2013 Q2	44.98 Million SEK	13.89%
2013 Q1	39.49 Million SEK	-17.68%
2012 Q1	31.69 Million SEK	2.01%
2012 Q3	40.53 Million SEK	11.67%
2012 Q2	36.3 Million SEK	14.53%
2012 FY	154.2 Million SEK	57.29%
2012 Q4	47.98 Million SEK	18.36%
2011 Q2	24.58 Million SEK	18.92%
2011 Q3	21.7 Million SEK	-11.71%
2011 Q4	31.06 Million SEK	43.12%
2011 FY	98.03 Million SEK	26.07%
2011 Q1	20.67 Million SEK	6.65%
2010 Q4	19.38 Million SEK	-8.84%
2010 FY	77.76 Million SEK	85.98%
2010 Q3	21.26 Million SEK	4.78%
2010 Q2	20.29 Million SEK	20.67%
2010 Q1	16.81 Million SEK	35.56%
2009 Q1	6.88 Million SEK	0.0%
2009 Q3	11.81 Million SEK	10.37%
2009 FY	41.81 Million SEK	2.05%
2009 Q4	12.4 Million SEK	4.99%
2009 Q2	10.7 Million SEK	55.52%
2008 FY	40.97 Million SEK	7.65%
2007 FY	38.06 Million SEK	22.11%
2006 FY	31.17 Million SEK	-4.16%
2005 FY	32.52 Million SEK	38.77%
2004 FY	23.43 Million SEK	92.31%
2003 FY	12.18 Million SEK	0.0%

Peer Operating Expenses Comparison of RaySearch Laboratories AB (publ)

Name	Operating Expenses	Operating Expenses Difference
Aino Health AB (publ)	13.31 Million SEK	-5915.333%
Bonzun AB (publ)	5.00 SEK	-16014019900.0%
Kontigo Care AB (publ)	43.23 Million SEK	-1752.145%
Medhelp Care Aktiebolag (publ)	100.87 Million SEK	-693.787%
Surgical Science Sweden AB (publ)	367.6 Million SEK	-117.819%

Global Stocks Search

RaySearch Laboratories AB (publ) (RAY-B.ST)

Operating Expenses Summary of RaySearch Laboratories AB (publ)

Annual Operating Expenses Chart of RaySearch Laboratories AB (publ) (2023 - 2003)

Historical Annual Operating Expenses of RaySearch Laboratories AB (publ) (2023 - 2003)

Peer Operating Expenses Comparison of RaySearch Laboratories AB (publ)